P21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells

Oncogene

Volumn 33, Issue 50, 2014, Pages 5716-5728

  Kreis, N N ^a   Sanhaji, M ^a   Rieger, M A ^a,b,c   Louwen, F ^a   Yuan, J ^a  

^a GOETHE UNIVERSITY   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Aurora B; Cdk1; chromosome segregation; cytokinesis; p21

Indexed keywords

AURKB PROTEIN, HUMAN; AURORA B KINASE; CCNB1 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN BINDING;

GENETICS; HCT116 CELL LINE; HELA CELL LINE; HUMAN; MCF 7 CELL LINE; METABOLISM; MITOSIS; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

AURORA KINASE B; CELL LINE, TUMOR; CYCLIN B1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HCT116 CELLS; HELA CELLS; HUMANS; MCF-7 CELLS; MITOSIS; NEOPLASMS; PROTEIN BINDING;

EID: 84889001029     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.518     Document Type: Article

References (61)

1. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
2. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
3. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701-704.
4. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211: 90-98.
5. Bloom J, Pagano M. To be or not to be ubiquitinated? Cell Cycle 2004; 3: 138-140.
6. Pei XH, Xiong Y. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 2005; 24: 2787-2795.
7. Gartel AL, Tyner AL. Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 1999; 246: 280-289.
8. Martin-Caballero J, Flores JM, Garcia-Palencia P, Serrano M. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res 2001; 61: 6234-6238.
9. Brugarolas J, Bronson RT, Jacks T. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J Cell Biol 1998; 141: 503-514.
10. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 2000; 20: 6147-6158.
11. Yang W, Velcich A, Mariadason J, Nicholas C, Corner G, Houston M et al. p21(WAF1/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo. Cancer Res 2001; 61: 6297-6302.
12. Adnane J, Jackson RJ, Nicosia SV, Cantor AB, Pledger WJ, Sebti SM. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene 2000; 19: 5338-5347.
13. Roninson IB. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 2002; 179: 1-14.
14. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 2003; 13: 65-70.
15. Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell 2008; 14: 159-169.
16. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9: 400-414.
17. Gartel AL. p21(WAF1/CIP1) and cancer: a shifting paradigm? Biofactors 2009; 35: 161-164.
18. Charrier-Savournin FB, Chateau MT, Gire V, Sedivy J, Piette J, Dulic V. p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Mol Biol Cell 2004; 15: 3965-3976.
19. Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res 2010; 704: 12-20.
20. Smits VA, Klompmaker R, Vallenius T, Rijksen G, Makela TP, Medema RH. p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem 2000; 275: 30638-30643.
21. Hall CC, Watkins JD, Ferguson SB, Foley LH, Georgopapadakou NH. Inhibitors of farnesyltransferase and Ras processing peptidase. Biochem Biophys Res Commun 1995; 217: 728-732.
22. Medema RH, Klompmaker R, Smits VA, Rijksen G. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene 1998; 16: 431-441.
23. Dulic V, Stein GH, Far DF, Reed SI. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol Cell Biol 1998; 18: 546-557.
24. Dash BC, El-Deiry WS. Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity. Mol Cell Biol 2005; 25: 3364-3387.
25. Niculescu III AB, Chen X, Smeets M, Hengst L, Prives C, Reed SI. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 1998; 18: 629-643.
26. Bates S, Ryan KM, Phillips AC, Vousden KH. Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression. Oncogene 1998; 17: 1691-1703.
27. Lanni JS, Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 1998; 18: 1055-1064.
28. Waldman T, Kinzler KW, Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995; 55: 5187-5190.
29. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497-1501.
30. Vassilev LT, Tovar C, Chen S, Knezevic D, Zhao X, Sun H et al. Selective smallmolecule inhibitor reveals critical mitotic functions of human CDK1. Proc Natl Acad Sci USA 2006; 103: 10660-10665.
31. Baus F, Gire V, Fisher D, Piette J, Dulic V. Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J 2003; 22: 3992-4002.
32. van der Waal MS, Hengeveld RC, van der Horst A, Lens SM. Cell division control by the Chromosomal Passenger Complex. Exp Cell Res 2012; 318: 1407-1420.
33. Hummer S, Mayer TU. Cdk1 negatively regulates midzone localization of the mitotic kinesin Mklp2 and the chromosomal passenger complex. Curr Biol 2009; 19: 607-612.
34. Mayer TU, Kapoor TM, Haggarty SJ, King RW, Schreiber SL, Mitchison TJ. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 1999; 286: 971-974.
35. Mishima M, Kaitna S, Glotzer M. Central spindle assembly and cytokinesis require a kinesin-like protein/RhoGAP complex with microtubule bundling activity. Dev Cell 2002; 2: 41-54.
36. Glotzer M. Animal cell cytokinesis. Annu Rev Cell Dev Biol 2001; 17: 351-386.
37. Lindqvist A, van ZW, Karlsson RC, Wolthuis RM. Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression. PLoS Biol 2007; 5: e123.
38. Wolf F, Wandke C, Isenberg N, Geley S. Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells. EMBO J 2006; 25: 2802-2813.
39. Lindqvist A, Rodriguez-Bravo V, Medema RH. The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 2009; 185: 193-202.
40. Yuan J, Eckerdt F, Bereiter-Hahn J, Kurunci-Csacsko E, Kaufmann M, Strebhardt K. Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1. Oncogene 2002; 21: 8282-8292.
41. Amador V, Ge S, Santamaria PG, Guardavaccaro D, Pagano M. APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol Cell 2007; 27: 462-473.
42. Wolf F, Sigl R, Geley S. '⋯ The end of the beginning': cdk1 thresholds and exit from mitosis. Cell Cycle 2007; 6: 1408-1411.
43. Pomerening JR, Ubersax JA, Ferrell Jr JE. Rapid cycling and precocious termination of G1 phase in cells expressing CDK1AF. Mol Biol Cell 2008; 19: 3426-3441.
44. Trakala M, Fernandez-Miranda G, Perez dC I, Heeschen C, Malumbres M. Aurora B, prevents delayed DNA replication and premature mitotic exit by repressing p21 (Cip1). Cell Cycle 2013; 12: 7.
45. Zimniak T, Fitz V, Zhou H, Lampert F, Opravil S, Mechtler K et al. Spatiotemporal regulation of Ipl1/Aurora activity by direct Cdk1 phosphorylation. Curr Biol 2012; 22: 787-793.
46. Barrett RM, Osborne TP, Wheatley SP. Phosphorylation of survivin at threonine 34 inhibits its mitotic function and enhances its cytoprotective activity. Cell Cycle 2009; 8: 278-283.
47. Tsukahara T, Tanno Y, Watanabe Y. Phosphorylation of the CPC by Cdk1 promotes chromosome bi-orientation. Nature 2010; 467: 719-723.
48. Nakajima Y, Cormier A, Tyers RG, Pigula A, Peng Y, Drubin DG et al. Ipl1/Auroradependent phosphorylation of Sli15/INCENP regulates CPC-spindle interaction to ensure proper microtubule dynamics. J Cell Biol 2011; 194: 137-153.
49. Date D, Dreier MR, Borton MT, Bekier ME, Taylor WR. Effects of phosphatase and proteasome inhibitors on Borealin phosphorylation and degradation. J Biochem 2012; 151: 361-369.
50. Xu Z, Ogawa H, Vagnarelli P, Bergmann JH, Hudson DF, Ruchaud S et al. INCENPaurora B interactions modulate kinase activity and chromosome passenger complex localization. J Cell Biol 2009; 187: 637-653.
51. Mishima M, Pavicic V, Gruneberg U, Nigg EA, Glotzer M. Cell cycle regulation of central spindle assembly. Nature 2004; 430: 908-913.
52. Jiang W, Jimenez G, Wells NJ, Hope TJ, Wahl GM, Hunter T et al. PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell 1998; 2: 877-885.
53. Mollinari C, Kleman JP, Jiang W, Schoehn G, Hunter T, Margolis RL. PRC1 is a microtubule binding and bundling protein essential to maintain the mitotic spindle midzone. J Cell Biol 2002; 157: 1175-1186.
54. Hu CK, Ozlu N, Coughlin M, Steen JJ, Mitchison TJ. Plk1 negatively regulates PRC1 to prevent premature midzone formation before cytokinesis. Mol Biol Cell 2012; 23: 2702-2711.
55. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994; 76: 1013-1023.
56. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der LN, Bahram F, Beuger V et al. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 2003; 22: 351-360.
57. Kreis NN, Sommer K, Sanhaji M, Kramer A, Matthess Y, Kaufmann M et al. Longterm downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1). Cell Cycle 2009; 8: 460-472.
58. Sanhaji M, Friel CT, Kreis NN, Kramer A, Martin C, Howard J et al. Functional and spatial regulation of mitotic centromere-associated kinesin by cyclin-dependent kinase 1. Mol Cell Biol 2010; 30: 2594-2607.
59. Sanhaji M, Louwen F, Zimmer B, Kreis NN, Roth S, Yuan J. Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53. Cell Cycle 2013; 12: 9 1340-51.
60. Yuan J, Sanhaji M, Kramer A, Reindl W, Hofmann M, Kreis NN et al. Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo. Am J Pathol 2011; 179: 2091-2099.
61. Kreis NN, Sanhaji M, Kramer A, Sommer K, Rodel F, Strebhardt K et al. Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16/18-infected cancer cells. Oncogene 2010; 29: 5591-5603.